Immunocore PRAME Investor & Analyst Event at ESMO 2022
Paris,
September 9, 2022
Following the presentation at ESMO, Immunocore will host an in-person and webcasted investor and analyst event at 6:30 PM CEST / 12:30 PM EDT on Friday, September 9th.
Date & Time: Friday, September 9th
Registration begins at 6:15 PM CEST
Presentation with hors d’oeuvres to follow from 6:30 to 8:00 PM CEST
Location: Espace56, Montparnasse Tower
Address: 33 Av. du Maine, 75015, Paris, France
The webcast will be available on the 'Events' section of the Immunocore website

Immunocore
[IMCR]
$2,334 MM MCap
A pioneering, commercial-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease, with the first TCR therapeutic to receive regulatory approval. [more information]
Event Contact

William Windham
Solebury Strategic Communications
Solebury Strategic Communications